Back to User profile » Dr Shu-Qiang Weng
Paper published by Dr Shu-Qiang Weng:
Original Research
The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease
Zhang DY, Zhu L, Liu HN, Tseng YJ, Weng SQ, Liu TT, Dong L, Shen XZ
Drug Design, Development and Therapy 2019, 13:2249-2270
Published Date: 5 July 2019